Related Experiment Video
Updated: Nov 4, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.1K
Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction
Manisha Ramphul1, David K H Lo1,2, Erol A Gaillard1,2
1Department of Paediatric Respiratory Medicine, Leicester Children's Hospital, University Hospitals Leicester, Leicester, UK.
Journal of Asthma and Allergy
|May 28, 2021
Summary
Precision medicine tailors asthma treatment for children by identifying unique traits. This approach optimizes care for severe asthma, improving outcomes and quality of life.
Area of Science:
- Pediatric Pulmonology
- Clinical Immunology
- Pharmacogenomics
Background:
- Asthma is a complex respiratory condition with diverse phenotypes and endotypes.
- Severe pediatric asthma significantly impacts quality of life, healthcare costs, and mortality.
- Current treatments require enhanced precision for individual patient needs.
Purpose of the Study:
- To review the personalized approach to assessing and managing severe asthma in children.
- To explore the application of precision medicine in pediatric asthma care.
- To discuss current and emerging biologic therapies for severe asthma.
Main Methods:
- Literature review of precision medicine strategies in pediatric severe asthma.
- Analysis of deep phenotyping techniques for identifying treatable traits.
- Examination of licensed and emerging biologic treatments and their indications.
Main Results:
- Precision medicine enables targeted therapy based on environmental, immunological, and genetic factors.
- Deep phenotyping is crucial for effective treatment selection in severe pediatric asthma.
- Biologic therapies offer new avenues for managing severe asthma phenotypes.
Conclusions:
- Personalized assessment and management are essential for severe pediatric asthma.
- Identifying treatable traits through deep phenotyping guides precision medicine.
- Biologics represent a significant advancement in treating severe asthma, with ongoing research into novel therapies.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
901
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
901
01:30Asthma-IV: Diagnostic and Management
2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.4K
01:23Inhaled Medications
506
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
506
01:26Asthma-II: Pathophysiology and Classification
3.5K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
770
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
770